Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
New paper investigating the relation between early stage amyloid burden and white matter‐tract microstructure alterations
New paper investigating the relation between early stage amyloid burden and white matter‐tract microstructure alterations 01 Apr 2021 Lyduine Collij and colleagues just published a new paper in the journal Alzheimer's & Dementia......
AMYPAD presents at AD/PD 2021
AMYPAD presents at AD/PD 2021 30 Mar 2021 Gemma Salvadó gave an oral presentation at AD/PD based on her work conducted within the AMYPAD project......
Recruitment update
Recruitment update 26 Mar 2021 AMYPAD PHNS: currently 881 participants recruited of which 663 have been scanned......
Recruitment status (as 26 March, 2021)
Recruitment status (as 26 March, 2021)